AES_2012

Day 1
Epilepsy Specialist Symposium: First Seizure: Diagnosis, Treatment and Prognosis
The educational program that kicked off the 2012 American Epilepsy Society (AES) Annual Meeting was the Epilepsy Specialist Symposium. This was the second year of the highly-valued program, and it contained a number of unique presentations directed towards algorithms in the diagnosis and treatment of epilepsy, with a goal of sharing the collective knowledge and best practices from experiences clinicians throughout the field.
VIDEO: Sheryl R. Haut, MD discusses clinical and economic significance of an appropriate initial assessment
Dr. Sheryl Haut, MD, an Associate Professor of Clinical Neurology at the Albert Einstein College of Medicine, discusses the current diagnostic challenges and educational gaps in primary epilepsy care, and notes the clinical and economic impacts of an appropriate initial assessment in management.
Current Opportunities and Future Goals of Epilepsy Research
Epilepsy is a disease that adversely affects the quality of life of millions, and poses significant clinical and economic challenges to the healthcare and managed care communities. Major improvements to epilepsy research and care have been made throughout the years, but improvement throughout the spectrum is still needed. In today's featured lecture, Dr. Jaideep Kapur, MD, PhD discusses the epilepsy community's goals and opportunities.
VIDEO: Scott C. Baraban, PhD discusses the current trend in epilepsy research
Dr. Scott Baraban, PhD, a Professor and William K. Bowes Endowed Chair in Neuroscience Research at the University of California, San Francisco, discusses the current trends of epilepsy research and the future direction of epilepsy care, particularly noting the role of gene therapy in management.
Day 2
Annual Fundamentals of Epilepsy Symposium, Part 1: Mechanism of Action of the New AEDs
The Annual Fundamentals of Epilepsy Symposium featured lectures around practical considerations for use of newer anti-epileptic drugs (AEDs). Starting with the fundamentals of mechanism of action (MOA), this overview brought into perspective the complexity and heterogeneity of the treatments for epilepsy, which mirroring the disorders that they are used to treat.
VIDEO: Dr. Tobias Loddenkemper, MD discusses the challenges and goals associated with the treatment of refractory status epilepticus (SE)
Dr. Tobias Loddenkemper, MD, the Assistant Professor in Neurology at Harvard Medical School, discusses the challenges and goals associated with the treatment of refractory status epilepticus (SE) in the pediatric populations, especially noting the cognitive and developmental considerations.
Annual Fundamentals of Epilepsy Symposium, Part 2: The Clinical Pharmacokinetics and Drug Interactions of the Newest AEDs
The Annual Fundamentals of Epilepsy Symposium featured lectures that focused on the practical considerations regarding the use of newer anti-epileptic drugs (AEDs). This portion of the symposium continued the discussion on newer AEDs, reviewing the clinical impact and significance of drug interactions, which are often variable.
VIDEO: Dr. Andrea O. Rossetti, MD discusses refractory status epilepticus
Dr. Andrea O. Rossetti, MD, the Head of the EEG/Epilepsy Unit in the Department of Clinical Neurosciences at the Centre Hospitalier Universitaire Vaudois (CHUV) defines refractory status epilepticus and discusses why the disorder is of particular concern among the healthcare and managed care communities.
Annual Fundamentals of Epilepsy Symposium, Part 3: Generic Antiepileptic Drugs: Fact and Fiction
The Annual Fundamentals of Epilepsy Symposium featured lectures that discussed the practical considerations regarding the use anti-epileptic drugs (AEDs). This presentation highlighted one of the ongoing controversies associated with pharmacologic management of epilepsy: the impact of generic substitution on clinical outcomes.
Day 3
VIDEO: Dr. Josep O. Dalmau, MD, PhD discusses autoimmune and paraneoplastic pathways
Dr. Josep O. Dalmau, MD, PhD, an Adjunct Professor in the Department of Neurology at the University of Pennsylvania, addresses the importance of acknowledging the roles of autoimmune and paraneoplastic pathways in the management of epilepsy disorders.
Current Obstacles to Optimal Epilepsy Management: A Call for Increased Awareness and Further Education
In a presentation titled "Barriers to Optimal Care", Nicholas Schiltz, BS and J. Pacheco-Phillips discuss how their respective studies have emphasized and highlighted the substantial need for increased awareness and further education among healthcare professionals to truly improve how epilepsy management, as well as care delivery and quality, is provided to the various patient populations.
Presidential Symposium: The IOM Report 2012: Epilepsy Across the Spectrum - Promoting Health and Understanding
The Presidential Symposium featured presentations that discussed the Institute of Medicine’s (IOM) 2012 report entitled “Epilepsy Across the Spectrum - Promoting Health and Understanding”. The IOM report was developed to help increase the awareness of epileptic syndromes and to improve the outcomes of epilepsy care.
VIDEO: Dr. David M. Labiner, MD discusses the implications of the IOM report on the future of epilepsy research and therapeutics
Dr. David M. Labiner, MD, a Professor and Head of the Department of Neurology at The University of Arizona, College of Medicine, discusses the implications of the IOM (Institute of Medicine) report on the future of epilepsy research and therapeutics.
VIDEO: Dr. Barbara C. Jobst, MD discusses clinical and economic implications of implanted devices for epilepsy management
Dr. Barbara C. Jobst, MD, the Director of the Dartmouth Epilepsy Program at Dartmouth-Hitchcock Medical Center, discusses the clinical and economic implications of implanted devices for epilepsy management, and describes the current obstacles that clinicians are encountering with implanted devices in practice.